Symdeko Kit
Product Images NDC 51167-113

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Symdeko (NDC 51167-113). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Vertex Pharmaceuticals Incorporated, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Symdeko 01)

Chemical structure of the active ingredient combination tezacaftor and ivacaftor in SYMDEKO, illustrating the molecular arrangement with various functional groups and atoms.*

FDA Label Image

Chemical Structure (Symdeko 02)

Chemical structure diagram of Tezacaftor and Ivacaftor, the active ingredients in SYMDEKO. The diagram shows molecular rings, bonds, and functional groups characteristic of these compounds.*

FDA Label Image

Figure 2 (Symdeko 04)

A line graph showing the absolute change in ppFEV1 LS Means with 95% confidence intervals over multiple visits (BL, D15, WK4, WK8, WK12, WK16, WK24). Two groups are compared: TEZ/IVA (tezacaftor and ivacaftor) represented by circles and placebo represented by triangles. The TEZ/IVA group shows an increasing trend in ppFEV1 over time, while the placebo group shows a decreasing trend. The x-axis is labeled 'Visit' and the y-axis 'Absolute Change in ppFEV1, LS Means (95% CI).*

FDA Label Image

Logo (Symdeko 04a)

FDA Label Image

Logo (Symdeko 04b)

FDA Label Image

Principal Display Panel (Kit Carton)

Packaging label for SYMDEKO kit by Vertex Pharmaceuticals Incorporated. Contains tezacaftor/ivacaftor 100 mg/150 mg and ivacaftor 150 mg tablets. The kit includes 56 tablets with 4 weekly blister cards, each having 14 tablets (7 tezacaftor/ivacaftor and 7 ivacaftor). Instructions for dosing morning and evening tablets with fat-containing food are displayed on the label.*

FDA Label Image

Principal Display Panel (Kit Carton)

Packaging label for SYMDEKO kit containing 56 tablets (tezacaftor/ivacaftor 50 mg/75 mg and ivacaftor 75 mg tablets) by Vertex Pharmaceuticals Incorporated. The label includes instructions to take tablets morning and evening 12 hours apart with fat-containing food, and states the product is a 4-week supply with 4 weekly blister cards, each containing 14 tablets. The label also features the NDC 51167-113-01 and describes the tablet types and usage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.